Clinical and prognostic characterization of atrial fibrillation due to an accessory pathway

Authors

  • Arnaldo Rodríguez León Hospital Universitario Celestino Hernández Robau
  • Eudis Reyes Mozo Hospital Universitario Celestino Hernández Robau
  • Ramiro R. Ramos Ramírez Hospital Provincial Universitario Cardiocentro Ernesto Guevara
  • Gustavo Padrón Peña Hospital Provincial Universitario Cardiocentro Ernesto Guevara
  • Raimundo Carmona Puerta Hospital Provincial Universitario Cardiocentro Ernesto Guevara
  • Elibet Chávez González Hospital Provincial Universitario Cardiocentro Ernesto Guevara

Keywords:

atrial fibrillation, electrophisiology, sudden death

Abstract

Introduction and objectives: Atrial fibrillation is the most common arrhythmia in adults, with a prevalence of 0.4 percent in the general population. It is the main cause of embolic events and serious hemodynamic alterations, having important clinical, social and economic repercussions. Besides, it is the second most frequent arrhythmia in patients with an accessory pathway. The objective of the study is to characterise atrial fibrillation with anterograde conduction through an accessory pathway. Method: A descriptive, prospective and longitudinal study was carried out in 26 patients who were treated at the Cardiac Electrophysiology Services of the Ernesto Che Guevara Cardiology Hospital in Santa Clara during a year period. The variables related to the prevalence of atrial fibrillation, risk factors, circumstances of appearance, therapeutic options and predictors of sudden death, were studied. Results: It was determined a prevalence 34.2 percent with a predominance of the male gender. The most important risk factor was the existence of previous events of atrial fibrillation in 35 percent of the patients, which appeared most frequently during rest periods. There was a predominance of the left pathways (54 %) and 84 percent of the patients required medication to achieve an acute reversion. Conclusions: Pre-excited atrial fibrillation presents an important prevalence in our environment. There was a predominance of the male gender and the left pathways. The mean RR interval during the pre-excitation was 213 milliseconds and there were minimal RR intervals of less than 170 milliseconds.

Downloads

Download data is not yet available.

References

1. Almendral Garrote J, Marín Huerta E, Medina Moreno O, Peinado Peinado R, Pérez Álvarez L, Ruiz Granell R, et al. Guías de Práctica Clínica de la Sociedad Española de Cardiología en Arritmias Cardíacas. Rev Esp Cardiol. 2001;54:307-67.

2. Fuster V. Aproximación terapéutica a la epidemiología de la fibrilación auricular. Rev Esp Cardiol. 2002;55:27-32.

3. Peters NS, Schilling RJ, Kanagaratmam P, Markides V. Atrial Fibrillation: strategies to control, combat, and cure. Lancet. 2002;359:593-603.

4. Basson CT. A molecular basis for Wolff-Parkinson-White syndrome. N Engl J Med. 2001;344:1861-4.

5. Gollob MG, Green MS, Tang ASL , Gollob T, Akihiko KaribeRN, Al-Sayegh H, et al . Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med. 2001;344:1823-31.

6. Takatsuki S, Mitamura H, Ieda M, Ogawa S. Accessory pathway associated with an anomalous coronary vein in a patient with W.PW Syndrome. J Cardiovasc Electrophysiol. 2002;12:1080-2.

7. Klein GJ. Atrial fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med. 2002;301:1080-5.

8. Silverman DI, Manning WJ: Strategies for cardiovertion of atrial fibrillation. Time for a change? N Engl J Med. 2001;244:1468-70.

9. Campbell RWF. Atrial fibrillation in the preexcitation syndrome. Am J Card. 2002;40: 414-20.

10. Rubestein JJ, Schulman PM. Clinical spectrum of the atrial fibrillation. Circulation. 2001;46:5-13.

11. Villacastin JP, Alfonso F. Ensayos clínicos presentados en el 50º Congreso Anual del American College of Cardiology (Orlando, 18-21 de marzo de 2001). Rev Esp Cardiol. 2001;54(7):892-905.

12. Planas F, Feliu A, Teresa P, Pujol M, Romero C, Sadurní J, et al. Perfil clínico de la fibrilación auricular paroxística idiopática (registro 'FAP'). Rev Esp Cardiol. 2001;54:838-44.

13. Carmona Puerta R, Ramos Ramírez R, Padrón Peña G, Nápoles Lizano M, Satorre Igualada JA, López Vega B. Fibrilación auricular en el Síndrome de WPW. Rev Fed Arg Cardiol. 2005;35:387-91.

14. Farré J, Villacastin JP, Torrecilla EG, Balaguer J, Martinell J, Fraile J, et al. Síncope en pacientes con vías accesorias auriculoventriculares. En: García Civera R, Sanjuan Mañez R, Cosin Aguilar J, López Merino V, editores. Síncope. Barcelona: MCR; 1989. p. 293-315.

15. Zegarra Carhuaz R. Ablación transcateter con radiofrecuencia y tratamiento definitivo del síndrome de Wolf-Parkinson-White. Diagnóstico. 2006;45(1):54-57.

16. Arenal A, Castel MA, López M, Merino JL. Actualización en arritmias y electrofisiología cardiaca. Rev Esp Cardiol. 2009;62(Suppl 1):67-79.

17. García I, Macías A, Díaz E. Registro Español de Ablación con Cateter. VI Informe Oficial de la Sección de Insuficiencia Cardiaca y Arritmias de la Sociedad Española de Cardiología (2006). Rev Esp Cardiol. 2007;60:1188-96.

18. Nademanee K, Schwab MC, Kosar EM, Karwecki M, Moran MD, Visessook N. Clinical outcomes of catheter substrate ablation for high risk patients with atrial fibrillation. J Am Coll Cardiol. 2008;51:843-9.

19. Segovia J, Bermejo J, Alfonso F. Resumen de los ensayos clínicos presentados en la 57ma Sesión Científica Annual del American College of Cardiology (Chicago, Estados Unidos, 30 de Marzo-2 de Abril del 2008). Rev Esp Cardiol. 2008;61:726-37.

20. Soylu M, Demir AD Ozdemir O, Soylu O, Topaloğlu S, Korkmaz S, et al. Increased P wave dispersion after the radiofrequency catheter ablation in overt preexcitation patients: the role of atrial vulnerability. Int J Cardiol. 2004;95:167-170.

21. Tercedor L, Atienza F, Díaz E, Guerra JM. Arritmias y electrofisiología cardiaca. Rev Esp Cardiol. 2008;61:27-36.

22. Pappone C, Santinelli V Rosanio S, Vicedomini G, Nardi S, Pappone A, et al. Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with WPW pattern: results from a large prospective long-term follow up study. J Am Coll Cardiol. 2003;41:239-41.

23. Kannel WB, Abbot RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation. The Framingham Study. N Engl J Med. 2004;306:1018-22.

24. Brand FN, Abbot RD. Characteristics and prognosis of lone atrial fibrillation. 30 year follow-up in the Framingham study. JAMA. 2003;254:3449-53.

Downloads

Published

2009-09-10

How to Cite

1.
Rodríguez León A, Reyes Mozo E, Ramos Ramírez RR, Padrón Peña G, Carmona Puerta R, Chávez González E. Clinical and prognostic characterization of atrial fibrillation due to an accessory pathway. CorSalud [Internet]. 2009 Sep. 10 [cited 2025 Nov. 6];1(3). Available from: https://revcorsalud.sld.cu/index.php/cors/article/view/1078

Issue

Vol. 1 No. 3 (2009)

Section

ORIGINAL ARTICLES

Categories

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.